Healthcare in 2025: smarter, more personal, more connected. As the co-founder of Hive Services and a partner at Dedicated VC, Benjamin Tillier has witnessed remarkable transformations in health tech, from visionary ideas to tangible breakthroughs. Looking ahead to 2025, he identifies seven trends shaping a future where healthcare is more personalised, accessible, and proactive in Luxembourg and beyond.
1. AI: a catalyst for predictive healthcare
AI will continue to evolve from a supportive tool to an integral driver of healthcare innovation. By analysing complex datasets, identifying patterns, and predicting outcomes, AI will accelerate diagnostics and help prevent diseases before they manifest.
This is not wishful thinking. Researchers at the Luxembourg Institute of Health (LIH) have already developed Vocalive, an AI tool that enables the development of vocal biomarkers to detect and monitor various conditions and symptoms (e.g., diabetes, depression, and fatigue). Similar technologies are expected to become standard in the coming years, providing noninvasive diagnostic tools accessible to patients worldwide.
Likewise, Luxembourg’s participation in the new Artificial Intelligence for Parkison’s Disease (AIPD) doctoral network, an EU-financed programme aimed at educating the next generation of medical data scientists, highlights the country’s commitment to advancing AI-driven solutions for complex conditions.
2. Wearable technology: from monitoring to preventive care
Wearables are on track to transition from data collection devices to becoming enablers of preventive healthcare. In 2025, the integration of wearables into chronic disease management will reach new heights, allowing real-time health monitoring to inform personalised treatments and early interventions.
Luxembourg’s leadership in wearable innovation is evident in the work of the Luxembourg Centre for Systems Biomedicine (LCSB), where researchers are developing digital biomarkers to track the progression and treatment response in Parkinson’s disease. By turning raw health data into actionable insights, wearable technologies will shift the focus from reactive care to prevention, clinical decision support, and telemonitoring – overall improving outcomes for millions worldwide.
Wearable technologies, such as telemonitoring devices or integrated digital therapeutics, are clear examples of health tech solutions with proven clinical benefits that deserve reimbursement. These solutions are similar to traditional treatments or medications. However, navigating national assessment frameworks like Germany’s DiGA or France’s Pécan remains complex, and no unified cross-border approach currently exists in Europe.
With its strategy to become a health tech hub, Luxembourg has a unique opportunity to lead as a reference point for guiding innovators toward European reimbursement. We are building this expertise at Hive to help health tech companies navigate these challenges.
3. Digital healthcare platforms: a new era of efficiency
These platforms enable seamless integration of health data, advanced therapies, and remote monitoring and we’ll see them increasingly support clinical decision-making and improve outcomes in the near future.
Luxembourg is home to several innovators shaping this space. tVNS Technologies offers a digital therapeutic platform using transcutaneous vagus nerve stimulation to treat conditions like depression and epilepsy. MyelinH is advancing personalised neuro-rehabilitation through brain-machine interfaces, enabling tailored care directly in patients’ homes.
On the software side, tuomi develops robust digital solutions for managing patient data and optimizing workflows in hospitals and clinics, while ITTM Solutions focuses on integrating complex health datasets, ensuring researchers and clinicians can securely analyse and utilise data for better patient care.
These innovations demonstrate the potential for digital platforms and automation to bridge gaps in care while addressing diverse patient needs.
4. Reproductive health: tackling the fertility challenge
With sperm counts declining by 26% every decade and 1 in 6 couples now facing infertility challenges, the demand for advanced reproductive technologies is dramatically increasing.
Companies like Legacy, a company I invested in last summer with Dedicated, are already expanding access to fertility services, democratising individuals’ tools for planning their reproductive futures. Fertility innovation will address medical needs and reflect cultural shifts, with workplaces, insurers, and policymakers increasingly integrating fertility support into their frameworks.
5. Space-enabled research: the new frontier for life sciences
Space is no longer just a frontier for astronauts—it’s becoming a critical environment for advancing life sciences. The unique conditions of microgravity enable groundbreaking research that could transform healthcare on Earth. From regenerative medicine to drug discovery, space-based research opens opportunities that traditional labs cannot replicate and we’ll witness more projects come to life in 2025.
Luxembourg, with its thriving space and health tech sectors, is uniquely positioned to lead this charge. Companies like ExoBiosphere are leveraging microgravity to study cellular growth and develop treatments for chronic diseases and regenerative medicine. Similarly, Yuri provides platforms for conducting biological experiments in space, enabling researchers to explore how cells, tissues, and organisms react to the conditions of microgravity.
By fostering collaborations between these two fields, Luxembourg is carving out a leadership role in space-enabled research, where innovations born in orbit hold the potential to reshape healthcare here on Earth.
6. Venture capital: fueling innovation
As a partner at Dedicated VC, I’ve seen firsthand how vital venture capital is for driving innovation in all industries. Since 2019, we’ve been committed to supporting ventures shaping the world of tomorrow in many areas, including healthcare. However, Luxembourg needs more VC players in the ecosystem to truly position itself as an innovation hub.
I’m excited to see Catalpa Ventures setting up here, a new VC investment fund focused on early-stage health tech, led by brilliant entrepreneurs—it’s a move perfectly aligned with the country’s national strategy.
By attracting more capital, we can bring top entrepreneurs and scale the most promising ideas in Luxembourg. This will attract more capital, even more entrepreneurs, and so on. You can see the virtuous circle we have to strive for.
7. Luxembourg rising to become Europe’s gateway to health tech innovation
In 2025, Luxembourg will continue solidifying its position as a premier health tech hub, attracting global talent, startups, and investments. Strategic initiatives like Hive Services and HE:AL Campus are not just fostering local innovation but connecting Luxembourg to the broader European market, creating a gateway for health and life sciences breakthroughs to scale globally.
As a central player in this ecosystem, Hive will continue supporting innovators by bridging gaps between research, industry, investments, and policy. Our mission is clear: to create an environment where transformative ideas can flourish and ensure Luxembourg leads the way in shaping the future of health.
